In Alcohol addiction Acamptas 333 Tablet is a medicine used, along with social support and counseling, to help people recover from alcohol addiction and to avoid having the urge to drink alcohol again. Acamptas 333 Tablet starts working from the very first dose and is a very safe and effective way of treating alcohol addiction.
It is not known whether it is safe to consume alcohol with Acamptas 333 Tablet. Please consult your doctor.
Acamptas 333 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Acamptas 333 Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Acamptas 333 Tablet does not usually affect your ability to drive.
Acamptas 333 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Acamptas 333 Tablet may be needed. Please consult your doctor. Use of Acamptas 333 Tablet is not recommended in patients with severe kidney disease.
Acamptas 333 Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Acamptas 333 Tablet may be needed. Please consult your doctor. Limited information is available on the use of Acamptas 333 Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.
If you miss a dose of Acamptas 333 Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Consern Pharma Limited || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Psycormedies || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sanity Pharma || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Shatayushi Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Enrico Pharmaceuticals || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Neosys Medicare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Ryon Pharma || ₹14.5/tablet (25% cheaper)